当前位置:
X-MOL 学术
›
J. Child Adolesc. Psychopharmacol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Neurocognitive Outcomes from Memantine: A Pilot, Double-Blind, Placebo-Controlled Trial in Children with Autism Spectrum Disorder
Journal of Child and Adolescent Psychopharmacology ( IF 1.9 ) Pub Date : 2021-09-17 , DOI: 10.1089/cap.2021.0010 Latha Valluripalli Soorya 1 , Louis Fogg 2 , Edith Ocampo 1 , Madison Printen 1 , Sarah Youngkin 1 , Danielle Halpern 3 , Alexander Kolevzon 3 , Soo Lee 1 , David Grodberg 4 , Evdokia Anagnostou 5
Journal of Child and Adolescent Psychopharmacology ( IF 1.9 ) Pub Date : 2021-09-17 , DOI: 10.1089/cap.2021.0010 Latha Valluripalli Soorya 1 , Louis Fogg 2 , Edith Ocampo 1 , Madison Printen 1 , Sarah Youngkin 1 , Danielle Halpern 3 , Alexander Kolevzon 3 , Soo Lee 1 , David Grodberg 4 , Evdokia Anagnostou 5
Affiliation
Objective: Studies interrogating therapeutics which alter the excitation-inhibition balance in the treatment of autism spectrum disorder (ASD) have reported mixed results on social and behavioral outcomes.
中文翻译:
美金刚的神经认知结果:一项针对自闭症谱系障碍儿童的试点、双盲、安慰剂对照试验
目的:对改变自闭症谱系障碍 (ASD) 治疗中兴奋-抑制平衡的疗法进行研究的研究报告了社会和行为结果的混合结果。
更新日期:2021-09-21
中文翻译:
美金刚的神经认知结果:一项针对自闭症谱系障碍儿童的试点、双盲、安慰剂对照试验
目的:对改变自闭症谱系障碍 (ASD) 治疗中兴奋-抑制平衡的疗法进行研究的研究报告了社会和行为结果的混合结果。